These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23837158)

  • 1. Basal cell carcinoma: hedgehog pathway inhibitors and beyond.
    Walls B
    Cutis; 2013 Jun; 91(6):E1-4. PubMed ID: 23837158
    [No Abstract]   [Full Text] [Related]  

  • 2. Harnessing hedgehog for the treatment of basal cell carcinoma.
    Harms KL; Dlugosz AA
    JAMA Dermatol; 2013 May; 149(5):607-8. PubMed ID: 23677088
    [No Abstract]   [Full Text] [Related]  

  • 3. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway.
    Sekulic A; Mangold AR; Northfelt DW; LoRusso PM
    Curr Opin Oncol; 2013 May; 25(3):218-23. PubMed ID: 23493193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hedgehog- and mTOR-targeted therapies for advanced basal cell carcinomas.
    Piérard-Franchimont C; Hermanns-Lê T; Paquet P; Herfs M; Delvenne P; Piérard GE
    Future Oncol; 2015 Nov; 11(22):2997-3002. PubMed ID: 26437034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision medicine and precision therapeutics: hedgehog signaling pathway, basal cell carcinoma and beyond.
    Mohan SV; Chang AL
    Semin Cutan Med Surg; 2014 Jun; 33(2):68-71. PubMed ID: 25085664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
    Kudchadkar R; Lewis K; Gonzalez R
    Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hedgehog antagonist GDC-0449 is effective in the treatment of advanced basal cell carcinoma.
    Amin SH; Tibes R; Kim JE; Hybarger CP
    Laryngoscope; 2010 Dec; 120(12):2456-9. PubMed ID: 20927781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging treatments and signaling pathway inhibitors.
    Tang JY; Marghoob AA
    Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S14-8. PubMed ID: 22177102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hedgehog Pathway Inhibition.
    Sekulic A; Von Hoff D
    Cell; 2016 Feb; 164(5):831. PubMed ID: 26919418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hedgehog signaling in basal cell carcinoma.
    Otsuka A; Levesque MP; Dummer R; Kabashima K
    J Dermatol Sci; 2015 May; 78(2):95-100. PubMed ID: 25766766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hedgehog pathway inhibition and the race against tumor evolution.
    Atwood SX; Chang AL; Oro AE
    J Cell Biol; 2012 Oct; 199(2):193-7. PubMed ID: 23071148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vismodegib in metastasized basal cell carcinoma].
    Reinders MG; Dirix L; Mosterd K; van Doorn R
    Ned Tijdschr Geneeskd; 2013; 157(12):A6011. PubMed ID: 23515044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral hedgehog-pathway inhibitors for basal-cell carcinoma.
    Lear JT
    N Engl J Med; 2012 Jun; 366(23):2225-6. PubMed ID: 22670909
    [No Abstract]   [Full Text] [Related]  

  • 14. Hedgehog hopes lifted by approval... and stung by failure.
    Allison M
    Nat Biotechnol; 2012 Mar; 30(3):203. PubMed ID: 22398601
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hedgehog inhibitors. New promising treatment of advanced basal cell carcinoma].
    Wolodarski M; Lapins J; Hansson J
    Lakartidningen; 2013 Apr 24-May 6; 110(17-18):886-8. PubMed ID: 23717940
    [No Abstract]   [Full Text] [Related]  

  • 16. Vismodegib: a hedgehog pathway inhibitor for locally advanced and metastatic basal cell carcinomas.
    Sobanko JF; Okman J; Miller C
    J Drugs Dermatol; 2013 Oct; 12(10 Suppl):s154-5. PubMed ID: 24085062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vismodegib (Erivedge) for basal cell carcinoma.
    Med Lett Drugs Ther; 2012 Jul; 54(1394):53-4. PubMed ID: 22777303
    [No Abstract]   [Full Text] [Related]  

  • 18. Hedgehog signaling pathway: a novel target for cancer therapy: vismodegib, a promising therapeutic option in treatment of basal cell carcinomas.
    Abidi A
    Indian J Pharmacol; 2014; 46(1):3-12. PubMed ID: 24550577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vismodegib, a hedgehog pathway inhibitor for adults with locally advanced or metastatic basal cell carcinoma.
    Wilkes GM
    Oncology (Williston Park); 2012 Aug; 26(8 Suppl Nurse Ed):31-3. PubMed ID: 25375009
    [No Abstract]   [Full Text] [Related]  

  • 20. Sonic Hedgehog pathway inhibitors: from clinical trials to clinical practice.
    Yan BY; Hibler BP; Menge T; Dunn L; Ho AL; Rossi AM
    Br J Dermatol; 2019 May; 180(5):1260-1261. PubMed ID: 30693471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.